Cargando…
Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters
BACKGROUND. Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DC...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710320/ https://www.ncbi.nlm.nih.gov/pubmed/34966844 http://dx.doi.org/10.1097/TXD.0000000000001277 |
_version_ | 1784623125883781120 |
---|---|
author | Goussous, Naeem Alvarez-Casas, Josue Dawany, Noor Xie, Wen Malik, Saad Gray, Stephen H. Barth, Rolf N. LaMattina, John C. |
author_facet | Goussous, Naeem Alvarez-Casas, Josue Dawany, Noor Xie, Wen Malik, Saad Gray, Stephen H. Barth, Rolf N. LaMattina, John C. |
author_sort | Goussous, Naeem |
collection | PubMed |
description | BACKGROUND. Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DCD LT outcomes. METHODS. Retrospective review of all patients who underwent DCD LT between 2005 and 2017 was performed. We compared outcomes of patients who were transplanted before 2014 (historic group) with those who were transplanted between 2014 and 2017 (modern group). RESULTS. We identified 112 patients; 44 were in the historic group and 68 in the modern group. Donors in the historic group were younger (26.5 versus 33, P = 0.007) and had a lower body mass index (26.2 versus 28.2, P = 0.007). DHT (min) and CIT (h) were significantly longer in the historic group (21.5 versus 14, P < 0.001 and 5.3 versus 4.2, P < 0.001, respectively). Fourteen patients (12.5%) developed IC, with a significantly higher incidence in the historic group (23.3% versus 6.1%, P = 0.02). There was no difference in graft and patient survival between both groups. CONCLUSION. In appropriately selected recipients, minimization of DHT and CIT may decrease the incidence of IC. These changes can potentially expand the DCD donor pool. |
format | Online Article Text |
id | pubmed-8710320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-87103202021-12-28 Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters Goussous, Naeem Alvarez-Casas, Josue Dawany, Noor Xie, Wen Malik, Saad Gray, Stephen H. Barth, Rolf N. LaMattina, John C. Transplant Direct Liver Transplantation BACKGROUND. Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DCD LT outcomes. METHODS. Retrospective review of all patients who underwent DCD LT between 2005 and 2017 was performed. We compared outcomes of patients who were transplanted before 2014 (historic group) with those who were transplanted between 2014 and 2017 (modern group). RESULTS. We identified 112 patients; 44 were in the historic group and 68 in the modern group. Donors in the historic group were younger (26.5 versus 33, P = 0.007) and had a lower body mass index (26.2 versus 28.2, P = 0.007). DHT (min) and CIT (h) were significantly longer in the historic group (21.5 versus 14, P < 0.001 and 5.3 versus 4.2, P < 0.001, respectively). Fourteen patients (12.5%) developed IC, with a significantly higher incidence in the historic group (23.3% versus 6.1%, P = 0.02). There was no difference in graft and patient survival between both groups. CONCLUSION. In appropriately selected recipients, minimization of DHT and CIT may decrease the incidence of IC. These changes can potentially expand the DCD donor pool. Lippincott Williams & Wilkins 2021-12-23 /pmc/articles/PMC8710320/ /pubmed/34966844 http://dx.doi.org/10.1097/TXD.0000000000001277 Text en Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Liver Transplantation Goussous, Naeem Alvarez-Casas, Josue Dawany, Noor Xie, Wen Malik, Saad Gray, Stephen H. Barth, Rolf N. LaMattina, John C. Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters |
title | Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters |
title_full | Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters |
title_fullStr | Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters |
title_full_unstemmed | Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters |
title_short | Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters |
title_sort | ischemic cholangiopathy postdonation after circulatory death liver transplantation: donor hepatectomy time matters |
topic | Liver Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710320/ https://www.ncbi.nlm.nih.gov/pubmed/34966844 http://dx.doi.org/10.1097/TXD.0000000000001277 |
work_keys_str_mv | AT goussousnaeem ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters AT alvarezcasasjosue ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters AT dawanynoor ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters AT xiewen ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters AT maliksaad ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters AT graystephenh ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters AT barthrolfn ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters AT lamattinajohnc ischemiccholangiopathypostdonationaftercirculatorydeathlivertransplantationdonorhepatectomytimematters |